We're at the first joint CRF & BRC Conference today, which is focusing on achieving impact through collaboration. We'll be leading a session tomorrow for early career researchers. @nihr.bsky.social @imperialmed.bsky.social

Professor Karen Brown (Leicester ECMC) is discussing her prevention trial COLO-PREVENT at #PrevConf25. Prof Brown is also the co-chair of the ECMC supported UK Therapeutic Cancer Prevention Network 👉https://www.ecmcnetwork.org.uk/groups/uk-therapeutic-cancer-prevention-network-group-uktcpn

Check out the work of the UK Therapeutic Cancer Prevention Network at #PrevConf25 (poster 99). The group champions prevention research and encourages collaboration & knowledge exchange. Find out more: www.ecmcnetwork.org.uk/groups/uk-th...

Today Karolin Kroese, Programme Lead in the #ECMC Programme Office is taking part in a panel discussion on clinical trials in oncology at the Outsourcing in Clinical Trials UK & Ireland 2025 conference #clinicaltrials

The ECMC Programme Office is on the ground at #ASCO25! We're in Chicago connecting with global partners, championing the UK’s leadership in experimental cancer medicine, and supporting our network’s investigators across the event! #ECMC #CancerResearch #ClinicalTrials @ascocancer.bsky.social

It's International Clinical Trials Day and the team is at the #RDF25 presenting on how the ECMC has contributed to the implementation of NCVR for complex early phase and advanced therapy oncology trials #clinicaltrials

Huge thanks to Diane for sharing her experience of taking part in an early phase clinical trial 💙 Her insight is inspiring and a powerful reminder of the difference patients make to research. #InternationalClinicalTrialsDay #ICTD2025 #FocusOnCamCancer @ecmc-uk.bsky.social @cambridgebrc.bsky.social

The ECMC team are up in Manchester for a few days at the RDF Conference and tomorrow we will be presenting on all the work we've been doing around study set-up #RDF25

That’s a wrap on an insightful, energising day at the #ECMC2025 Network Meeting! Huge thanks to all speakers, panellists & attendees. Let’s keep the momentum going! 💪

Last but not least! Harriet Unsworth (@cruk-mi.bsky.social) shows how digital health tech can maximise impact and support trial success. From tools to outcomes. #ECMC2025 #DigitalHealth

Now Yemi Akala (Leicester ECMC) takes us through the opportunities and pitfalls of decentralised trial models. What’s the future of remote oncology research? #ECMC2025 #DecentralisedTrials

Next up... Prof. Matthew Sydes (@england.nhs.uk) on unlocking the full potential of healthcare systems data to accelerate early phase trial delivery. #ECMC2025 #DataDrivenResearch

Our first session explores Patient Centric Tech! How can innovation break down barriers to trial access? Steve Nabarro & Ben Hood explore tech that’s designed with patients at its heart. #ECMC2025 #PatientCentric

Now we’re powering through into our late afternoon sessions on how innovation and digital tools can transform patient engagement & trial delivery in early phase research! #ECMC2025 #DigitalTrials

Session C: Equity of Access 🌍 Representation matters. This session looks at how ECMC can improve equity in trial access—through design, engagement, and tackling health inequality. #ECMC2025 #InclusiveResearch

Session B: Translating Policy to Practice 🏛️➡️🧪 Turning national strategy into local success. This breakout dives into real-world approaches to improving trial setup and delivery. #ECMC2025 #ResearchPolicy

Session A: Quantum Leap in Oncology Research 🚀 What breakthroughs will redefine cancer care? Experts explore paradigm-shifting innovations—from T-cells to ADCs to cancer vaccines. #ECMC2025

Our delegates are now breaking out into paralell sessions. We'll be discussing key challenges facing the network and wider clinical research landscape #ECMC2025

How can ECMC build international partnerships? Dr Natalie Cook (@oncocook) & Emma Kinloch (@London_Em1) join the international Consortia conversation on learning globally, acting locally. #ECMC2025 #TrialNetworks

Prof Christophe Massard & Dr Anna Patrikidou (@gustaveroussy.fr) showcase the CLIP network’s approach to early phase trials in France. What can we learn? Let’s find out. #ECMC2025 #GlobalCollaboration

Stuart Lavin (Bayer) & Dimitrios Magkos(@icr.ac.uk) are highlighting how partnership drives innovation in radiopharmaceutical research. #ECMC2025

How can the UK regulatory landscape better support early phase trial delivery? Dr Kingyin Lee (@mhragovuk.bsky.social) & Kate Greenwood (@hralatest.bsky.social) explore challenges and opportunities—followed by an open Q&A. #ECMC2025

Prof Patrick Chinnery addresses a pressing issue: the declining UK clinical research workforce. A vital conversation begins now with our ECMC Leads on how to reverse the decline #ECMC2025 #ResearchCareers

We're kicking off today’s ECMC Annual Network Meeting! We’re live with a full agenda focused on innovation, collaboration, and equity in early phase cancer trials. #ECMC2025 #EarlyPhaseTrials

It was fantastic to see Dr. Frankie Fan, Prof. Karen Brown (Leicester ECMC) and their incredible colleagues at #AACR2025! sharing insights on clinical trial recruitment barriers in colorectal polyp prevention in today's late-breaking poster session!

We're listening to a fascinating update on GLIMPS (IL13R CAR-T for high-grade glioma) and MIGHTY (Multi-modular CAR-T cells targeting B7-H3 in CYP sarcoma) by Dr Karin Straathof (UCL paediatric ECMC)

We're continuing in the #CCLG2025's Clinical Trials (Solid & CNS Tumours session) with @newcastle-ecmc.bsky.social's Dr. Quentin Campbell-Hewson for an update on the New Agents Group!

Dr John Apps (Birmingham ECMC) is presenting MonoGerm next– A Phase II trial of carboplatin or vinblastine monotherapy induction prior to radiotherapy for intracranial germinoma. Looking forward to an insightful afternoon with updates on exciting advancements s for paediatric solid & CNS tumours!

🔬 We're now attending the Clinical Trials (Solid & CNS Tumours) session, chaired by Prof. Amos Burke from the Birmingham Paeds ECMC. Great to see so many of our network leads presenting during this afternoon's session!

Excited to see Prof. Dan Stark (Paediatric ECMC Leeds & TYA steering committee member) chairing the TYA Projects and Research session at #CCLG2025 The experts are discussing TYA research consent, Outcomes for TYA patients with cancer as well as Fertility research and care in Europe.

It's Day 2 here at @cclguk.bsky.social's annual conference. Diving into more insights on paediatric oncology and clinical research and looking forward to hearing from more experts and latest developments! #CCLG2025 #PaediatricOncology

What’s next for CYP oncology research? Professor Pam Kearns (Birmingham Paediatric ECMC) shares her thoughts at the Insights and Innovations sessions, discussing the future of CYP trials in the UK. #ECMC #CCLGResearch #PaediatricOncology #CCLG2025

Fantastic to be at the #EarlyCareerResearcher Symposium during #CCLG2025. The panel which includes Prof. Pam Kearns from our Birmingham Paediatric ECMC are discussing navigating complex networks in Paeds and TYA oncology, the power of mentorship, and working with funders!

We're excited to be at @cclguk.bsky.social's annual conference and are looking forward to having insightful conversations about the Paediatric and TYA oncology landscape. Come and chat to Lindsey and Sumair at ECMC stand 13 to hear about our work with children and young adults! #CCLG2025